News AstraZeneca PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 03:13:01 2024-04-25 am EDT			5-day change	1st Jan Change
11,979 ^GBX	+5.52%		+4.51%	+7.09%

08:58am	Miner Anglo American reviews takeover bid from rival BHP	AN
08:44am	Miner Anglo American eyes rival BHP takeover	AN

Miner Anglo American reviews takeover bid from rival BHP	02:58am	AN
Miner Anglo American eyes rival BHP takeover	02:44am	AN
AstraZeneca Earnings, Sales Rise, Beat Forecasts	02:37am	DJ
AstraZeneca Reports Growth in Q1 Attributable Profit, Total Revenue	02:30am	MT
Earnings Flash (AZN.L) ASTRAZENECA Posts Q1 EPS $1.40	02:13am	MT
AstraZeneca beats first-quarter revenue, profit estimates	02:06am	RE
AlzeCure publishes its interim report for January – March 2024	02:01am	AQ
Q1 2024 results	02:01am	BU
Stocks called down ahead of US GDP data	01:50am	AN
Sanofi Q1 profit slips on generic competition, forex effects	01:30am	RE
MORNING BID EUROPE-Gearing up for the tech roller-coaster ride	12:31am	RE
EMEA Morning Briefing : Shares Seen Lower; Earnings, U.S. GDP Data in Focus	12:16am	DJ
No record close for FTSE 100; mixed trade in US	Apr. 24	AN
No record close for FTSE 100; mixed trade in US	Apr. 24	AN
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	Apr. 24	MT
Astrazeneca - Voydeya approved in the EU as add-on treatment to ravulizumab or eculizumab for adults with the rare disease PNH who have residual haemolytic anaemia	Apr. 24	AQ
ASTRAZENECA : Bernstein reiterates its Buy rating	Apr. 24	ZD
Angle shares jump on supplier agreement with with AstraZeneca	Apr. 24	AN
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook	Apr. 24	AN
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	Apr. 24	CI

No results for this search

ASTRAZENECA : AstraZeneca should not be overlooked for long

April 03, 2024 at 10:26 am EDT